Antisense Therapeutics

Antisense Therapeutics is a biopharmaceutical drug discovery and development company whose mission is to create, develop and commercialize novel antisense therapeutics for a variety of drug candidates including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly.



Antisense Therapeutics Limited (ANP) is pleased to announce that it has agreed to issue, through a placement to existing major shareholders - Firebird Global Master Fund and Circadian Technologies...